GlassScriptPhysician profile
Audra L Clos
NPI 1952601122
$22,076.33
in general payments reported to CMS, 2019-2025
37 companies · $3,936 in 2025
The $3,936 reported for 2025 was more than what 88% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,433 · 2020: $2,024 · 2021: $1,877 · 2022: $2,214 · 2023: $2,674 · 2024: $5,918 · 2025: $3,936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,648 · Consulting Fee: $5,130 · Travel and Lodging: $650 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,648.48 |
| Consulting Fee | $5,130.00 |
| Travel and Lodging | $650.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $4,110.80 | 2022-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $3,104.48 | 2023-2025 | Zoryve |
| Abbvie INC. | $2,529.95 | 2019-2025 | Skyrizi, Rinvoq |
| Novartis Pharmaceuticals Corporation | $1,429.51 | 2019-2025 | |
| Janssen Biotech, INC. | $1,399.66 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $1,050.60 | 2019-2025 | Dupixent |
| Medimetriks Pharmaceuticals, INC. | $781.36 | 2019-2021 | |
| Galderma Laboratories, L.P. | $637.03 | 2019-2025 | Aklief, Oracea, Twyneo |
| Sun Pharmaceutical Industries INC. | $588.40 | 2019-2024 | Winlevi, Absorica Ld |
| Genzyme Corporation | $577.39 | 2019-2025 | |
| Lilly USA, LLC | $576.25 | 2019-2025 | Taltz, Ebglyss |
| Mayne Pharma Commercial LLC | $573.80 | 2019-2023 | |
| Amgen INC. | $557.39 | 2019-2025 | Otezla |
| Leo Pharma INC. | $553.54 | 2019-2025 | Adbry |
| Pfizer INC. | $548.99 | 2019-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $489.72 | 2019-2025 | Cimzia, Bimzelx |
| Incyte Corporation | $349.04 | 2021-2025 | Opzelura |
| Almirall LLC | $283.65 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $250.24 | 2022-2025 | Sotyktu |
| Organon LLC | $229.64 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $216.28 | 2020-2021 | |
| Epi Health, LLC | $214.24 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $200.75 | 2019-2025 | Jublia, Cabtreo, Siliq |
| Revance Therapeutics, INC. | $140.31 | 2024-2025 | Daxxify |
| Journey Medical Corporation | $137.20 | 2019-2023 | |
| Janssen Scientific Affairs, LLC | $120.72 | 2019 | |
| Celgene Corporation | $72.78 | 2019 | |
| Genentech USA, INC. | $72.51 | 2019-2022 | |
| Allergan, INC. | $72.29 | 2021-2022 | |
| Dermira, INC. | $63.50 | 2019-2021 | |
| Promius Pharma LLC | $40.77 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.50 | 2023 | Spevigo |
| Paratek Pharmaceuticals, INC. | $21.34 | 2023 | Nuzyra |
| Botanix Sb INC | $13.62 | 2025 | Sofdra |
| Biofrontera INC. | $13.44 | 2019 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 | |
| Aclaris Therapeutics, INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audra Clos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.